proteom
approach
use
mean
identifi
target
identifi
treat
varieti
infecti
agent
especi
true
agent
respons
emerg
infect
import
biodefens
keyword
reversephas
protein
microarray
mass
spectrometri
proteinprotein
interact
correspond
virus
develop
numer
eleg
strategi
manipul
host
cell
machineri
establish
product
infecti
cycl
interact
viral
protein
host
protein
play
import
role
infect
pathogenesi
often
bypass
tradit
host
defens
interferon
respons
apoptosi
hostvir
protein
interact
studi
use
varieti
proteom
approach
rang
genet
biochem
largescal
highthroughput
technolog
protein
interact
host
viral
protein
greatli
influenc
host
signal
transduct
pathway
review
focu
compar
proteom
inform
obtain
differ
technolog
integr
use
determin
function
aspect
host
respons
infect
briefli
review
evalu
techniqu
employ
elucid
viralhost
interact
primari
focu
protein
microarray
pma
mass
spectrometri
ms
potenti
tool
discoveri
novel
therapeut
target
mani
potenti
molecular
marker
target
protein
proteom
profil
expect
yield
clearer
direct
answer
function
pharmacolog
question
virus
evolv
arsen
mechan
infect
host
establish
product
infecti
cycl
host
turn
develop
innat
cellular
defens
block
infect
replic
virus
well
establish
introduct
viru
host
cell
alter
host
proteom
result
novel
protein
interact
novel
interact
may
occur
integr
host
compon
may
also
involv
viral
protein
comprehens
understand
molecular
mechan
underli
proteinprotein
interact
ppi
would
therefor
enabl
util
mechan
discoveri
antivir
drug
identif
viral
alter
host
protein
zheng
et
al
kshirsagar
et
al
mancon
et
al
omic
technolog
advanc
tremend
last
year
genom
transcriptom
push
gene
express
field
ahead
braun
gingra
mancon
et
al
noisakran
et
al
keat
et
al
howev
gene
express
profil
dataset
limit
necessarili
correl
steadi
state
protein
product
often
truli
repres
interactom
grave
haystead
noisakran
et
al
mancon
et
al
purpos
review
consid
host
protein
interact
one
anoth
viral
protein
form
distinct
complex
interactom
furthermor
genom
transcriptom
studi
alon
elucid
ppi
structur
function
level
mancon
et
al
ppi
studi
use
varieti
proteom
approach
rang
biochem
genet
largescal
highthroughput
technolog
zheng
et
al
kshirsagar
et
al
review
evalu
techniqu
employ
elucid
ppi
primari
focu
protein
microarray
pma
ms
potenti
tool
discoveri
novel
therapeut
strategi
multipl
tradit
molecular
biolog
biochem
approach
use
mani
decad
success
detect
ppi
howev
discuss
method
scope
review
review
includ
contextu
inform
popular
classic
method
employ
analyz
ppi
includ
yeast
twohybrid
system
coimmunoprecipit
coip
drew
bouwmeest
miernyk
thelen
white
howley
togeth
two
method
respons
deciph
interact
intact
databas
may
aranda
et
al
chen
et
al
system
popular
detect
binari
physic
interact
drew
bouwmeest
hsu
spindler
white
howley
method
reli
interact
bait
fusion
protein
prey
fusion
protein
activ
report
gene
select
marker
advantag
system
econom
use
process
larg
sampl
size
drew
bouwmeest
white
howley
exampl
pool
librari
screen
approach
use
librari
known
prey
clone
combin
test
pool
bait
strain
exampl
determin
ppi
system
demonstr
influenza
viru
protein
human
staufen
protein
vivo
falc
et
al
cho
et
al
coupl
genom
wide
express
profil
system
suggest
larg
number
hostvir
protein
interact
shapira
et
al
tafforeau
et
al
addit
system
use
identifi
nine
put
host
cell
protein
interact
nsm
rift
valley
fever
viru
rvfv
vaccinia
viru
interact
varieti
protein
mccraith
et
al
sever
acut
respiratori
syndromecoronaviru
sarscov
protein
selfinteract
andor
interact
viral
protein
form
multimer
complex
von
brunn
et
al
numer
cellular
protein
bind
dengu
viru
denv
protein
khadka
et
al
unfortun
procedur
also
limit
interact
two
protein
detect
drew
bouwmeest
white
howley
ppi
observ
outsid
natur
context
alway
requir
independ
valid
relev
model
system
analysi
ppi
tradit
involv
bind
system
protein
interest
tag
recoveri
method
coimmunoprecipit
co
ip
miernyk
thelen
noisakran
et
al
coip
reli
idea
fairli
strong
interact
two
protein
stabl
stringent
elut
condit
high
salt
one
partner
interact
precipit
interact
protein
also
precipit
detect
antibodybas
method
coip
usual
use
sepharoseprotein
column
briefli
antibodi
specif
protein
interest
incub
prepar
protein
sampl
form
antibodyprotein
complex
analyz
sdspage
western
blot
process
modern
approach
includ
matrix
assist
laser
desorptionion
time
flight
mass
spectrometri
malditof
ms
drew
bouwmeest
miernyk
thelen
zheng
et
al
exampl
use
coip
allow
identif
hostvir
ppi
denv
nonstructur
protein
human
heterogen
nuclear
ribonucleoprotein
noisakran
et
al
methyltransferas
domain
west
nile
viru
protein
mammalian
cgmpdepend
protein
kinas
protein
kinas
g
keat
et
al
vaccinia
viru
host
tail
interact
protein
kda
chen
et
al
addit
exampl
coip
studi
includ
venezuelan
equin
enceph
viru
nonstructur
protein
host
major
ribosom
phosphoprotein
montgomeri
et
al
ebola
viru
protein
host
inhibitor
jb
kinas
e
ikk
tankbind
kinas
prin
et
al
valuabl
inform
determin
coip
studi
major
drawback
techniqu
may
accur
represent
vivo
scenario
weak
transient
ppi
may
overlook
hsu
spindler
addit
method
emerg
analyz
ppi
util
new
gener
aptam
contain
chemic
modifi
nucleotid
aptam
short
singlestrand
oligonucleotid
bind
high
affin
specif
protein
peptid
small
molecul
gold
brodi
gold
one
method
use
systemat
evolut
ligand
exponenti
enrich
selex
select
aptam
librari
random
sequenc
ellington
szostak
gold
although
technolog
high
potenti
highthroughput
biomark
identif
difficulti
creat
high
affin
aptam
protein
target
gold
address
problem
new
form
aptam
develop
call
slow
offrat
modifi
adapt
somam
basi
somam
addit
function
group
give
aptam
proteinlik
properti
enabl
wider
varieti
high
affin
aptam
gold
et
al
aptamerbas
technolog
wave
advantag
requir
character
valid
standard
standard
affin
capturem
gold
et
al
due
limit
tradit
method
improv
approach
assess
ppi
demand
increas
capac
analyz
broad
rang
interact
system
biolog
approach
also
function
synergist
tradit
method
ppi
observ
isol
binari
interact
strengthen
need
new
approach
would
encompass
abil
identifi
ppi
also
relev
biolog
pathway
inform
recent
largescal
precis
proteom
base
ms
microarray
enabl
systemwid
character
hostbas
event
level
posttransl
modif
ppi
chang
protein
express
advanc
deliv
accur
unbias
quantit
inform
regard
protein
modif
respons
perturb
largescal
proteomicsbas
signal
research
continu
develop
integr
exist
novel
technolog
alongsid
improv
databas
like
understand
signal
network
undergo
signific
chang
come
year
pma
use
profil
ppi
lead
discoveri
possibl
drug
target
molecular
level
wulfkuhl
et
al
gulmann
et
al
wilson
et
al
mancon
et
al
basi
protein
microarray
array
immobil
protein
spot
arrang
slide
spot
contain
either
homogen
heterogen
set
bait
molecul
liotta
et
al
current
two
popular
type
pma
tradit
forward
phase
microarray
fpma
revers
phase
protein
microarray
rpma
liotta
et
al
sheehan
et
al
wilson
et
al
zhu
et
al
sutandi
et
al
fpma
bait
molecul
usual
antibodi
immobil
glass
slide
cell
lysat
sampl
antigen
place
array
layer
signalgener
antibodi
ad
allow
bind
signal
emit
posit
spot
array
fig
contrast
rpma
methodolog
immobil
test
sampl
analyt
antigen
slide
antibodi
appli
second
mobil
phase
rpma
format
immobil
differ
test
sampl
spot
mean
one
array
compris
hundr
thousand
differ
sampl
array
incub
signalgener
antibodi
obtain
posit
signal
fig
array
describ
fpma
protein
microarray
design
fix
immobil
multipl
bait
molecul
glass
slide
surfac
bait
usual
antibodi
fig
also
nucleic
acid
peptid
phage
lysat
liotta
et
al
wulfkuhl
et
al
sheehan
et
al
gulmann
et
al
wilson
et
al
hu
et
al
fpma
allow
simultan
measur
multipl
protein
singl
sampl
liotta
et
al
sheehan
et
al
gulmann
et
al
wilson
et
al
hu
et
al
analyt
either
serum
tissu
sampl
prelabel
often
fluorophor
place
array
layer
signalgener
antibodi
ad
analyt
allow
bind
signal
emit
posit
spot
array
liotta
et
al
gulmann
et
al
wilson
et
al
hu
et
al
studi
use
fpma
use
studi
wide
rang
topic
determin
proteom
profil
endogen
protein
lovo
colon
carcinoma
cell
expos
ioniz
radiat
identifi
regulatori
site
radiationinduc
apoptosi
signal
sreekumar
et
al
addit
applic
fpma
involv
profil
protein
tyrosin
phosphoryl
character
chang
posttransl
modif
acetyl
ubiquitin
mammalian
cell
ivanov
et
al
studi
develop
proteom
profil
cancer
progress
oral
caviti
cancer
tissu
sampl
combin
fpma
employ
laser
captur
microdissect
lcm
knezev
et
al
lcm
enabl
research
isol
cell
interest
heterogen
tissu
multipl
kind
cell
arriv
homogen
cell
popul
without
contamin
surround
nonrelev
cell
forward
phase
microarray
format
base
immobil
analyt
captur
reagent
antibodi
onto
solid
support
expos
analyt
immobil
analyt
probe
suitabl
conjug
antibodi
visual
util
sandwich
assaybas
approach
requir
two
wellperform
antibodi
b
rpma
character
immobil
analyt
onto
substrat
allow
direct
comparison
hundr
sampl
side
side
requir
one
wellperform
antibodi
increas
chanc
epitop
recognit
decreas
likelihood
nonspecif
interact
addit
technic
inform
lcm
reader
direct
espina
et
al
data
obtain
studi
illustr
exampl
appli
fpma
highthroughput
tool
profil
varieti
posttransl
modif
cell
differ
treatment
two
major
limit
procedur
follow
fluorophor
label
potenti
disrupt
bind
capabl
analyt
label
protein
sampl
result
high
background
due
nonspecif
bind
analyt
complex
mixtur
may
present
low
abund
alongsid
excess
protein
perform
serial
dilut
sampl
often
necessari
dilut
protein
concentr
allevi
high
background
issu
gulmann
et
al
addit
limit
fpma
requir
specif
antibodi
target
protein
differ
antibodi
design
introduc
potenti
variabl
compar
independ
experi
gulmann
et
al
rpma
protein
microarray
immobil
test
sampl
analyt
slide
antibodi
appli
top
analyt
fig
compar
fpma
fig
rpma
newer
iter
tradit
fpma
technolog
develop
cancer
field
dr
lanc
liotta
emanuel
petricoin
iii
cell
popul
sampl
taken
cancer
tissu
subject
lcm
use
analyz
state
prosurviv
checkpoint
growth
regul
protein
wulfkuhl
et
al
paweletz
et
al
sinc
public
rpma
technolog
adopt
mani
research
group
appli
lcm
tissu
also
heterogen
tissu
sampl
cell
cultur
lysat
nishizuka
et
al
serumplasma
sampl
janzi
et
al
mueller
et
al
ovarian
effus
davidson
et
al
vitreou
davuluri
et
al
fine
needl
aspir
rapkiewicz
et
al
peptid
macbeath
schreiber
moreov
use
rpma
limit
preclin
research
studi
critic
compon
sever
clinic
trial
review
see
mueller
et
al
cancer
vanmet
et
al
wilson
et
al
einspahr
et
al
cellular
pathway
character
bacteri
infect
mechan
popova
et
al
immunolog
disord
viralhost
interact
wilson
et
al
einspahr
et
al
aguilarmahecha
et
al
narayanan
et
al
baer
et
al
austin
et
al
popova
et
al
rpma
capabl
monitor
protein
dynam
function
time
diseas
vs
nondiseas
state
treatment
sheehan
et
al
spurrier
et
al
quantit
monitor
protein
express
level
mani
sampl
simultan
liotta
et
al
wulfkuhl
et
al
sheehan
et
al
gulmann
et
al
hultschig
et
al
spurrier
et
al
wilson
et
al
hu
et
al
sutandi
et
al
rpma
technolog
provid
necessari
analyt
sensit
measur
even
ultralow
abund
protein
reason
combin
lcm
technolog
rpma
creat
power
analyt
tool
base
increas
sensit
reduc
sampl
volumeconcentr
input
requir
combin
hundr
thousand
sampl
singl
array
moreov
rpma
twosit
sandwichtyp
antibodi
array
requir
one
wellperform
primari
antibodi
detect
number
analyt
measur
much
greater
could
perform
forwardphas
array
typic
rpma
nanolit
nl
sampl
print
duplic
triplic
onto
glassback
nitrocellulos
slide
use
either
contact
sheehan
et
al
gulmann
et
al
obk
et
al
noncontact
schena
array
sourc
analyt
could
vitro
sampl
gener
cultur
cell
vivo
sampl
gener
anim
tissu
clinic
sampl
spot
size
ten
hundr
micron
diamet
rpma
platform
allow
thousand
sampl
fit
one
slide
hundr
slide
analyz
everi
array
run
give
approach
high
throughput
flavor
array
probe
singl
primari
antibodi
principl
similar
immunoassay
biggest
challeng
rpma
immunoassay
need
avail
high
qualiti
specif
antibodi
prior
applic
rpma
antibodi
valid
use
western
blot
demonstr
high
target
specif
current
develop
valid
antibodi
librari
individu
effort
lab
georg
mason
univers
current
possess
larg
repertoir
valid
antibodi
relev
phosphoryl
unphosphoryl
protein
map
divers
node
mani
phosphosign
cascad
benefici
protein
microarray
field
combin
effort
futur
assembl
maintain
central
repositori
valid
rpmacertifi
antibodi
describ
workflow
rpma
fig
follow
exampl
rpma
studi
conduct
popova
et
al
studi
popova
et
al
use
rpma
identifi
phosphosign
protein
pathway
modul
cultur
human
cell
earli
order
minut
late
time
point
rvfv
infect
human
cell
infect
wildtyp
strain
rvfv
cell
lyse
variou
time
point
rpma
procedur
c
nl
sampl
equival
amount
materi
lyse
cell
array
nitrocellulos
slide
advantag
array
layout
sampl
print
point
dilut
seri
ensur
quantif
posit
signal
perform
linear
rang
slide
probe
one
differ
antibodi
specif
phosphoryl
total
form
signal
protein
antibodi
select
monitor
molecular
network
involv
host
respons
like
affect
viru
exposur
apoptot
cell
surviv
pathway
valid
rpma
data
level
multipl
select
protein
analyz
western
blot
use
antibodi
phosphoryl
total
form
protein
procedur
agreement
demonstr
rpma
enorm
technic
util
independ
also
function
synergist
capac
tradit
method
follow
imag
array
softwar
technolog
use
captur
quantifi
analyt
spot
similar
softwar
use
dna
microarray
analysi
ie
imagequ
ge
healthcar
life
scienc
pittsburgh
pa
microvigen
tm
vigenetech
north
billerica
softwar
packag
microvigen
includ
sever
featur
facilit
quantif
array
data
autom
spotboundari
detect
imag
contrast
enhanc
dust
scratch
remov
outlier
flag
region
background
correct
total
protein
neg
control
intern
refer
standard
normal
option
gulmann
et
al
data
normal
algorithm
rang
calibr
curv
normal
sevecka
macbeath
spikedin
intern
standard
normal
robustlinearmodel
normal
sboner
et
al
normal
respect
sampl
total
protein
exampl
popova
et
al
averag
total
level
cellular
protein
everi
time
point
determin
stain
sypro
rubi
protein
blot
stain
four
randomli
select
slide
throughout
print
run
popova
et
al
spot
find
softwar
program
convert
pixel
densiti
spot
numer
valu
mueller
et
al
microvigen
softwar
offer
autom
curvefit
approach
quantifi
analyt
across
fivepoint
dilut
curv
includ
replic
gulmann
et
al
addit
technic
inform
softwar
reader
direct
gulmann
et
al
downstream
biostatist
analysi
raw
normal
array
data
depend
highli
type
sampl
print
array
scientif
question
address
gener
mani
statist
method
employ
rpma
data
analysi
tradit
method
use
evalu
confid
interv
method
unsupervis
hierarch
cluster
kmean
cluster
selforgan
map
princip
compon
analysi
allow
mani
hundr
slide
imprint
sampl
time
size
pin
imprint
sampl
slide
determin
mani
hundr
thousand
analyt
print
everi
slide
slide
also
imprint
posit
controlsknown
analyt
predetermin
concentr
high
low
control
shown
slide
final
slide
also
contain
calibr
spot
dilut
seri
high
low
control
spot
calibr
permit
quantit
interpret
data
within
slide
permit
comparison
slide
multipl
experi
slide
array
queri
singl
predetermin
antibodi
total
number
slide
experi
determin
total
number
antibodi
word
total
number
desir
target
follow
antigen
antibodi
interact
slide
stain
intens
spot
slide
quantifi
rel
differ
signal
intens
biolog
distinct
analyt
plot
graphic
format
tool
use
determin
relationship
data
point
gener
microarray
gulmann
et
al
cluster
close
relat
data
point
determin
cutoff
point
make
data
biolog
sensibl
howev
statist
signific
differ
data
point
provid
hierarch
cluster
method
gulmann
et
al
common
statist
method
anova
ttest
mannwhitney
utest
employ
determin
differ
data
set
provid
prior
knowledg
classif
sampl
known
gulmann
et
al
sever
technolog
exist
graphic
map
protein
signal
pathway
activ
data
rpma
one
approach
overlay
rpma
data
static
imag
ppi
gener
accept
larger
scientif
commun
wellknown
pathway
human
cancer
cell
signal
map
dr
robert
weinberg
cscape
use
googl
map
api
overlay
cell
signal
map
rel
proteinphosphoprotein
abund
enabl
visual
identif
hot
spot
within
cell
signal
architectur
whole
activatednonactiv
signal
pathway
fig
anoth
approach
visual
protein
abund
proteinprotein
correl
ie
calcul
spearman
rho
analysi
bayesian
network
like
comput
analysi
use
gener
network
analysi
system
gephi
bastian
et
al
graph
gener
applic
graphic
illustr
influenc
pathway
compon
form
node
arc
node
repres
variabl
arc
statist
signific
relationship
variabl
one
strongest
advantag
rpma
abil
gener
multipl
hypothes
subsequ
test
develop
field
outcom
rpma
run
virtual
treasur
trove
inform
multipl
signal
event
analyz
singl
snapshot
time
one
alter
signal
event
form
basi
individu
hypothesi
involv
specif
viral
strain
individu
viral
protein
exampl
go
great
length
deciph
function
consequ
ppi
exemplifi
rpma
studi
conduct
popova
et
al
reveal
phosphoryl
activ
nfjb
signal
cascad
narayanan
et
al
demonstr
follow
studi
phosphoryl
serin
involv
phosphoryl
ijba
classic
nfjb
cascad
rvfv
util
host
nfjb
signal
cascad
establish
robust
infect
addit
group
demonstr
inhibit
nfjb
cascad
abl
inhibit
viral
replic
import
outcom
studi
viral
protein
nss
may
influenc
activ
statu
cascad
rpma
studi
also
reveal
tumor
suppressor
protein
phosphoryl
event
infect
studi
austin
et
al
expand
data
show
rvfv
infect
activ
phosphoryl
local
nucleu
follow
transient
interact
rvfv
virul
factor
nss
character
phosphoryl
prompt
investig
dna
damag
signal
pathway
rvfv
infect
baer
et
al
demonstr
rvfv
infect
induc
nssdepend
dna
damag
signal
respons
concurr
sphase
arrest
provid
evid
novel
function
nss
shown
directli
impact
viral
replic
collect
modif
phosphoprotein
signal
rvfv
examin
singl
rpma
studi
result
elucid
numer
cellular
mechan
play
import
role
viral
infect
subsequ
exploit
target
viral
replic
result
drawn
studi
illustr
high
throughput
identif
ppi
host
viru
lead
identif
potenti
therapeut
target
viral
infect
baer
et
al
inhibit
mapk
signal
pathway
character
host
signal
nonleth
lethal
strain
b
anthraci
popova
et
al
virtu
compar
natur
rpma
studi
open
avenu
detect
previous
unrecogn
host
respons
silenc
upon
infect
part
pathogen
process
popova
et
al
anoth
exampl
diagnost
current
applic
rpma
technolog
involv
effort
creat
rapid
accur
sensit
diagnost
tool
detect
biomark
sarscov
address
problem
zhu
et
al
develop
first
coronaviru
protein
rpma
entir
proteom
human
sarscov
viru
partial
proteom
coronavirus
imprint
microarray
probe
symptomat
patient
sera
zhu
et
al
presenc
viralspecif
antibodi
detect
use
goat
antihuman
igg
antibodi
zhu
et
al
analysi
microarray
reveal
increas
sensit
reactiv
accuraci
biomark
detect
sar
infect
individu
zhu
et
al
exampl
demonstr
feasibl
use
rpma
technolog
clinic
environ
detect
biomark
advent
novel
high
throughput
techniqu
rpma
greatli
expand
abil
gener
inform
dataset
complementari
approach
necessari
account
depend
antibodi
addit
antibodi
select
research
inher
direct
small
number
known
signal
event
modif
give
rise
need
complement
antibodi
valid
use
techniqu
independ
limit
get
around
inher
limit
bias
antibodybas
research
modern
quantit
ms
increasingli
use
balanc
direct
antibodybas
approach
de
chassey
et
al
zhou
et
al
patwa
et
al
patwa
et
al
msbase
proteom
limit
specif
site
protein
interest
make
suitabl
use
unbias
hypothesi
free
systemswid
manner
repres
fundament
differ
approach
studi
cell
signal
go
et
al
zheng
et
al
one
commonli
use
ms
approach
depend
peptid
separ
normal
perform
liquid
chromatographi
lc
tandem
ms
lcmsm
gonzalezgalarza
et
al
look
host
cell
signal
respons
complex
protein
sampl
may
deriv
whole
cell
biolog
fluid
protein
entir
sampl
may
process
often
prefer
perform
separ
techniqu
better
character
inform
protein
particular
biolog
interest
brewi
brennan
protein
separ
initi
perform
prior
step
method
one
dimension
two
dimension
gel
electrophoresi
column
chromatographi
affin
purif
follow
enzymat
digest
often
use
trypsin
sampl
prepar
critic
subsequ
data
interpret
particularli
deal
larg
dataset
gener
lcm
techniqu
subcellular
fraction
provid
cleaner
sampl
also
give
valuabl
protein
local
inform
compar
whole
cell
lysat
alon
brewi
brennan
gonzalezgalarza
et
al
biolog
fluid
also
possibl
remov
abund
protein
immunodeplet
enrich
altern
complimentari
method
global
protein
separ
resolv
protein
electrophoresi
subject
individu
protein
band
digest
lcm
brewi
brennan
method
mani
gel
segmentprotein
band
cut
process
identifi
numer
separ
protein
typic
workflow
individu
separ
protein
physic
isol
remov
trypsin
digest
result
peptid
separ
basi
rel
hydrophob
lc
tandem
ms
ms
ms
brewi
brennan
tandem
ms
data
use
search
exist
protein
databas
achiev
match
protein
spectra
base
amino
acid
sequenc
typic
deriv
msm
spectra
low
abund
larg
small
protein
howev
prove
difficult
resolv
use
gel
global
analysi
much
commonplac
trypsin
digest
entir
solubil
protein
mixtur
produc
peptid
soup
protein
sampl
gelfre
lcm
proteom
petricoin
et
al
peptid
separ
lc
basi
rel
hydrophob
charg
multidimension
separ
petricoin
et
al
extens
msm
databas
search
perform
identifi
mani
protein
origin
sampl
one
advantag
protein
interactom
map
workflow
possibl
achiev
quantit
data
time
introduc
peptid
label
step
isobar
tag
rel
absolut
quantif
itraq
method
use
label
peptid
intern
standard
perform
protein
label
stabl
isotop
label
amino
acid
cell
cultur
silac
without
need
addit
lcm
brewi
brennan
itraq
repres
method
differenti
multipl
condit
eight
sampl
simultan
wies
et
al
brewi
gadella
approach
lend
label
vivo
sampl
andor
primari
cell
label
appli
postsampl
prepar
exampl
itraq
use
investig
influenza
viru
infect
primari
human
macrophag
lietz
en
et
al
typic
two
set
sampl
differenti
label
stabl
isotop
one
sampl
light
form
heavi
form
label
depend
type
chemic
label
reagent
use
sampl
label
enzymat
digest
combin
subject
separationenrich
techniqu
follow
analysi
ms
quantit
comparison
chang
protein
express
level
quantifi
determin
ratio
peak
intens
light
heavi
form
gener
peptid
brewi
brennan
pairwis
comparison
peak
intens
peptid
label
heavi
light
form
label
serv
basi
quantit
protein
analysi
brewi
brennan
note
accuraci
quantit
measur
depend
label
incorpor
highest
level
accuraci
achiev
label
incorpor
earli
process
due
sampl
loss
process
variabl
silac
also
appli
studi
viral
infect
cell
cultur
provid
quantit
inform
regard
pathogenhost
cell
interact
brewi
gadella
zhou
et
al
toss
et
al
silac
cell
virus
differenti
grow
cell
popul
viru
within
cell
popul
media
contain
uniqu
stabl
isotop
label
amino
acid
becom
incorpor
newli
synthes
protein
eventu
supplant
equival
nonlabel
homolog
brewi
gadella
label
techniqu
greatli
reduc
sampl
complex
increas
label
effici
prior
sampl
prepar
allow
rel
quantif
protein
sampl
ms
brewi
gadella
analyz
mass
spectromet
pair
chemic
ident
peptid
differ
isotop
composit
differenti
label
amino
acid
induc
shift
masscharg
ratio
mz
comparison
unlabel
peptid
brewi
brennan
brewi
gadella
compar
intens
label
unlabel
z
peak
possibl
obtain
accur
quantit
data
rel
abund
label
unlabel
peptid
present
sampl
brewi
brennan
brewi
gadella
way
protein
increas
decreas
abund
virusinfect
compar
mock
drugtreat
cell
simultan
identifi
quantifi
brewi
brennan
brewi
gadella
rel
quantif
peptid
use
itraq
silac
label
coupl
lcmsm
bioinformat
analysi
one
popular
power
option
global
proteom
quantif
provid
excel
resourc
studi
host
cell
proteom
readili
appli
studi
hostpathogen
infect
wies
et
al
brewi
brennan
brewi
gadella
munday
et
al
proteom
biomark
discoveri
pathway
aim
combin
multidimension
fraction
label
method
along
msm
analysi
identifi
protein
uniqu
highli
abund
complex
sampl
obtain
specif
diseas
state
compar
profil
healthi
match
control
use
peptid
label
previous
mention
itraq
silac
sampl
diseaseaffect
healthi
control
sampl
run
side
side
ms
workflow
data
obtain
process
use
bioinformat
algorithm
program
itrack
itraq
search
differ
peak
intens
sampl
set
silacanalyz
silac
open
sourc
tool
fulli
autom
analysi
quantit
proteom
data
petricoin
et
al
wies
et
al
munday
et
al
silacanalyz
identifi
pair
isotop
envelop
fix
mz
separ
requir
prior
sequenc
identif
peptid
discrimin
pathogen
pattern
form
key
subset
protein
peptid
buri
among
entir
repertoir
thousand
protein
repres
sampl
spectrum
compar
control
group
potenti
identifi
recent
studi
human
respiratori
syncyti
viru
hrsv
use
silac
conjunct
lc
msm
allow
direct
simultan
identif
quantif
cellular
viral
protein
munday
et
al
reduc
sampl
complex
increas
data
return
potenti
protein
local
cell
fraction
nuclear
cytoplasm
extract
munday
et
al
novel
hrsvhost
cell
interact
includ
associ
antivir
respons
alter
subnuclear
structur
nucleolu
promyelocyt
leukemia
bodi
identifi
munday
et
al
addit
novel
chang
mitochondri
protein
function
cell
cycl
regulatori
molecul
nuclear
pore
complex
protein
nucleocytoplasm
traffick
protein
observ
infect
cell
munday
et
al
commonli
avail
bioinformat
program
ingenu
pathway
analysi
use
organ
expans
interrog
deriv
data
set
virusinfect
cell
valid
use
tradit
orthogon
assay
munday
et
al
lietz
en
et
al
studi
use
silac
conjunct
lc
msm
result
identif
potenti
interact
cellular
protein
along
six
viral
protein
munday
et
al
anoth
studi
use
flock
hous
viru
fhv
infect
drosophila
cell
profil
chang
protein
express
level
found
base
direct
analysi
intens
use
label
combin
lcmsm
go
et
al
overal
total
host
protein
identifi
quantifi
upregul
downregul
respons
viral
infect
go
et
al
stabl
isotop
label
tradit
use
compar
hostvir
proteom
labelfre
approach
becom
viabl
attract
altern
use
chromatograph
separ
high
mass
accuraci
measur
along
data
normal
method
moreov
informat
algorithm
employ
facilit
data
analysi
due
larg
dataset
obtain
lcm
experi
overal
highli
effect
compar
proteom
due
comprehens
high
throughput
natur
date
labelfre
quantit
proteom
approach
success
appli
analysi
numer
sampl
organ
human
serum
yeast
shewanella
oneidensi
fang
et
al
brewi
brennan
despit
signific
advanc
effort
challeng
remain
current
labelfre
method
associ
dynam
rang
measur
extent
proteom
coverag
confid
peptideprotein
identif
quantiz
accuraci
analysi
throughput
robust
present
instrument
issu
still
need
address
improv
technolog
reliabl
use
clinic
set
qian
et
al
findeisen
neumaier
mani
option
avail
quantit
unbias
proteom
studi
discuss
review
new
techniqu
util
tradit
novel
nextgener
target
proteom
start
shift
tradit
paradigm
use
discoverybas
identif
target
quantif
util
tripl
quadrupl
mass
spectromet
qqq
boja
rodriguez
shi
et
al
fung
et
al
discoverybas
strategi
goal
usual
identifi
mani
protein
possibl
goal
target
proteom
monitor
select
protein
interest
high
sensit
reproduc
quantit
accuraci
tradit
discoverybas
approach
peptid
ion
automat
select
mass
spectromet
fragment
basi
signal
intens
gener
rich
complex
tandem
mass
spectra
peptid
sequenc
requir
care
analysi
complex
bioinformat
contrast
use
target
workflow
qqq
mass
spectromet
program
detect
specif
peptid
ion
deriv
protein
interest
select
specif
precursor
ion
basi
mz
ratio
fragment
second
mass
filter
target
ion
select
guid
detector
quantif
result
trace
signal
intens
vs
retent
time
precursor
ionproduct
ion
pair
process
call
select
reaction
monitor
srm
multipl
reaction
monitor
mrm
lang
et
al
upfront
approach
much
labor
intens
develop
tradit
discoverybas
pipelin
reliabl
assay
gener
specif
protein
analysi
ms
data
rel
straightforward
uncompl
comparison
srm
matur
msbase
technolog
target
proteom
analysi
new
methodolog
obviat
need
labori
srm
assay
optim
current
develop
one
exampl
sever
novel
methodolog
swath
complex
mass
spectra
gener
dataindepend
acquisit
peptid
select
fragment
without
regard
signal
intens
queri
presenc
specif
peptid
use
librari
qualifi
peptid
fragment
spectra
gillet
et
al
ms
novel
approach
develop
continu
improv
push
field
rapidli
forward
toward
target
approach
provid
mani
viabl
option
look
proteom
interactom
hostpathogen
perspect
everi
toolset
discuss
review
strength
weak
combin
ms
along
high
throughput
method
protein
detect
rpma
conjunct
use
tradit
tool
mean
valid
screen
immunoblot
analysi
demonstr
abil
greatli
strengthen
inher
defici
individu
approach
use
orthogon
method
conjunct
thu
abl
arriv
much
wellround
comprehens
pictur
proteom
mechan
use
combin
patwa
et
al
mancon
et
al
previous
discuss
cellular
function
driven
complex
network
interact
protein
control
variou
signal
cascad
among
mechan
proteom
experi
describ
aim
paint
molecular
portrait
essenti
protein
activ
specif
cellular
state
compar
infect
vs
uninfect
state
fig
follow
statist
analysi
identifi
protein
significantli
chang
desir
analyt
state
describ
protein
list
gener
must
transform
inform
network
repres
function
chang
observ
diseas
state
sever
key
analyt
step
must
undertaken
develop
comprehens
network
includ
map
protein
id
function
crosscompar
protein
function
identifi
visual
analyz
protein
interact
network
sanzpamplona
et
al
addit
protein
function
structur
interact
databas
spars
repres
small
fraction
known
human
protein
hostpathogen
interact
databas
even
spars
kshirsagar
et
al
kshirsagar
carbonel
kleinseetharaman
tri
find
common
among
function
therefor
essenti
gener
complet
network
possibl
tool
ingenu
pathway
analysi
ipa
goulet
et
al
nation
institut
allergi
infecti
diseas
databas
annot
visual
integr
discoveri
david
huang
sherman
lempicki
cytoscap
sanzpamplona
et
al
among
other
use
identifi
common
statist
overrepres
pathway
ontolog
term
function
protein
list
use
interrog
broader
protein
interact
network
tool
draw
larg
public
databas
describ
protein
functionssuch
gene
ontolog
go
pathwayssuch
kegg
reactom
biocarta
protein
interact
databasessuch
dip
bind
intact
among
other
tool
also
use
identifi
import
pathway
interact
host
pathogen
protein
kshirsagar
et
al
goulet
et
al
although
ms
experi
comprehens
measur
cellular
protein
issu
describ
variabl
protein
abund
confound
experi
result
result
reproduc
identifi
individu
protein
confound
type
basic
network
analys
describ
previou
paragraph
sever
exist
tool
help
assess
similar
identifi
gene
function
merg
similar
protein
like
function
group
includ
sora
simgic
teng
et
al
tool
use
merg
protein
express
inform
protein
function
across
differ
method
rpma
tandem
ms
help
cluster
proteom
data
function
bin
use
identifi
pathway
interact
network
sora
simgic
among
other
measur
function
similar
among
protein
term
inform
content
context
go
term
allow
precis
bin
protein
similar
function
role
teng
et
al
network
gener
proteom
experi
often
highli
complex
benefit
greatli
analysi
interact
visual
tool
help
teas
key
subnetwork
analysi
laboratori
valid
experi
tool
ipa
goulet
et
al
cytoscap
kacprowski
doncheva
albrecht
sanzpamplona
et
al
cscape
einspahr
et
al
allow
insight
visual
analysi
complex
cellular
network
analysi
allow
scientist
directli
interact
data
help
turn
inform
knowledg
key
cellular
function
affect
diseas
exampl
node
edg
within
network
may
weight
base
common
function
andor
direction
magnitud
express
identifi
key
connect
among
experiment
identifi
protein
protein
current
major
drug
target
choic
play
critic
role
process
modern
drug
design
host
protein
particularli
attract
target
pathogen
less
like
develop
obstruct
mutat
therapeut
develop
resist
therapeut
develop
typic
involv
numer
step
construct
drug
compound
base
structur
specif
drug
target
valid
therapeut
efficaci
drug
compound
evalu
drug
toxic
final
clinic
trial
rpma
ms
along
function
proteom
approach
employ
step
investig
process
use
ms
combin
use
high
throughput
antibodi
platform
allow
much
global
comprehens
direct
approach
studi
viral
infect
pathogen
state
matter
reveal
complex
event
within
infect
cell
compens
limit
techniqu
isol
posttransl
modif
includ
phosphoryl
acetyl
ubiquitinationar
specif
modif
alter
activ
individu
protein
target
cumul
effect
small
modif
regul
larg
signal
pathway
network
within
cell
comprehens
understand
molecular
mechan
underli
viral
infect
remain
major
challeng
discoveri
new
antivir
drug
host
suscept
factor
new
advanc
field
expect
aris
systemslevel
model
integr
proteom
genom
disciplin
current
wet
lab
techniqu
attempt
briefli
explor
import
benefit
use
two
power
proteom
techniqu
combinatori
capac
better
understand
molecular
relationship
virus
host
chiefli
look
cellular
signal
pathway
global
perspect
past
studi
alreadi
demonstr
viral
proteom
target
wide
rang
function
interconnect
modul
protein
within
human
interactom
use
global
systemslevel
approach
provid
relev
accur
valuabl
inform
go
et
al
brewi
gadella
munday
et
al
lietz
en
et
al
zhou
et
al
de
chassey
et
al
summar
protein
interact
studi
come
long
way
past
decad
term
technologyplatform
develop
protein
chemistri
togeth
use
microarray
bioinformat
tool
set
along
omic
identif
molecular
signatur
diseas
base
protein
pathway
signal
cascad
hold
great
promis
util
diseas
diagnosi
therapeut
develop
